Holding(s) in Company

Dechra Pharmaceuticals PLC

12 January 2024

 

veTR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
Merrill Lynch International	London	United Kingdom

5. Date on which the threshold was crossed or reached

10-Jan-2024

6. Date on which Issuer notified

11-Jan-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	7.285272	1.845725	9.130997	10400742
Position of previous notification (if applicable)	6.901602	1.878360	8.779962

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		8298354		7.285272
Sub Total 8.A	8298354		7.285272%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Right to Recall	N/A	N/A	16991	0.014917
Physical Swaps	03/06/2024	N/A	966106	0.848162
Sub Total 8.B1			983097	0.863079%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Swaps	17/04/2024	N/A	Cash	437610	0.384186
Swaps	31/07/2024	N/A	Cash	324556	0.284933
Swaps	08/11/2024	N/A	Cash	20000	0.017558
Swaps	18/11/2024	N/A	Cash	1904	0.001672
Swaps	02/12/2024	N/A	Cash	10000	0.008779
Swaps	17/12/2024	N/A	Cash	243780	0.214019
Swaps	18/12/2024	N/A	Cash	41053	0.036041
Swaps	23/12/2024	N/A	Cash	33840	0.029709
Swaps	30/12/2024	N/A	Cash	1745	0.001532
Swaps	02/01/2025	N/A	Cash	1129	0.000991
Swaps	03/02/2025	N/A	Cash	496	0.000435
Swaps	04/02/2025	N/A	Cash	258	0.000227
Swaps	06/05/2025	N/A	Cash	2920	0.002564
Sub Total 8.B2				1119291	0.982646%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Bank of America Corporation	Bank of America, National Association
Bank of America Corporation	Merrill Lynch International	6.932924		7.376157%
Bank of America Corporation	BofA Securities Europe SA

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

11-Jan-2024

13. Place Of Completion

United Kingdom

 

END